Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

35.83
+0.38001.07%
Post-market: 35.40-0.4300-1.20%18:28 EDT
Volume:4.80M
Turnover:172.05M
Market Cap:4.23B
PE:12.95
High:36.14
Open:35.45
Low:35.21
Close:35.45
52wk High:42.81
52wk Low:22.95
Shares:118.00M
Float Shares:109.00M
Volume Ratio:2.32
T/O Rate:4.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):1.64
ROE:12.20%
ROA:26.40%
PB:-20.33
PE(LYR):21.85

Loading ...

Indivior initiated with an Overweight at Barclays

TIPRANKS
·
Jun 18

U.S. RESEARCH ROUNDUP- Datadog, Jabil, Prologis

Reuters
·
Jun 18

REFILE-FACTBOX-UK Market Exodus: Companies that moved away from London listing in recent years

Reuters
·
Jun 16

Indivior Chief Scientific Officer Christian Heidbreder disposes of 18,586 shares for $707,779.16

Reuters
·
Jun 13

UK Market Exodus: Companies that moved away from London listing in recent years

Reuters
·
Jun 12

Indivior CFO Ryan Preblick sells 36,000 shares for $1.36 million

Reuters
·
Jun 10

Analysts Are Bullish on Top Healthcare Stocks: Elevance Health (ELV), Indivior (INDV)

TIPRANKS
·
Jun 05

Will Real-World SUBLOCADE Adherence Data Reshape Indivior Pharmaceuticals' (INDV) Long-Acting OUD Treatment Narrative

Simply Wall St.
·
May 23

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), AbCellera Biologics (ABCL) and Indivior (INDV)

TIPRANKS
·
May 22

Indivior study links monthly injectable buprenorphine adherence to lower opioid relapse risk

Reuters
·
May 20

Indivior’s Earnings Call Highlights SUBLOCADE-Driven Surge

TIPRANKS
·
May 20

Lifeward names Keith D. Rose chief medical officer

Reuters
·
May 19

Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership

TIPRANKS
·
May 16

Indivior eliminates chief scientific officer role; Heidbreder departs end-2026

Reuters
·
May 16

Indivior Pharmaceuticals Inc - to Eliminate Chief Scientific Officer Position Effective June 1, 2026 - SEC Filing

THOMSON REUTERS
·
May 16

Indivior Pharmaceuticals, Inc : Stifel Raises Target Price to $52 From $42

THOMSON REUTERS
·
May 06

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News

Simply Wall St.
·
May 05

Sector Update: Health Care

MT Newswires Live
·
May 04

Indivior Pharmaceuticals Enters $175 Million Accelerated Share Repurchase Agreement

MT Newswires Live
·
May 04

Indivior announces $175M accelerated share repurchase program

TIPRANKS
·
May 04